Australia Cancer Biomarkers Market Size & Outlook 2033

Australia Cancer Biomarkers Market Size, Share, Trends and Forecast by Profiling Technology, Biomolecule, Cancer Type, Application, End User, and Region, 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A33601

Australia Cancer Biomarkers Market Overview:

The Australia cancer biomarkers market size reached USD 686.6 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 2,526.5 Million by 2033, exhibiting a growth rate (CAGR) of 14.4% during 2025-2033. The market is experiencing steady growth, driven by advancements in early cancer detection and personalized treatment approaches. Increasing research activities, rising awareness among healthcare providers, and expanding applications of biomarkers across various cancer types are supporting market development. Strategic collaborations between research institutes and biotech firms further enhance innovation. Favorable healthcare policies also contribute to a positive outlook for the sector, boosting Australia Cancer Biomarkers share.

Report Attribute	Key Statistics
Base Year	2024
Forecast Years	2025-2033
Historical Years	2019-2024
Market Size in 2024	USD 686.6 Million
Market Forecast in 2033	USD 2,526.5 Million
Market Growth Rate 2025-2033	14.4%

Australia Cancer Biomarkers Market Trends:

Growing Adoption of Precision Medicine

The increasing focus on individualized cancer therapy in Australia is boosting demand for cancer biomarkers. Precision medicine adjusts treatment according to the unique genetic makeup and biomarker expression of each patient, allowing more specific therapies and better outcomes. Government and industry investment in genomic research, coupled with greater availability of high-throughput sequencing technology, has stepped up biomarker discovery. Hospitals and cancer centers are increasingly incorporating biomarker testing to inform treatment choices for tumors such as breast, lung, and colorectal. Regulatory approaches facilitating companion diagnostics are also propelling the Australia cancer biomarkers market growth. With efficacy and fewer side effects becoming more of a concern to patients and doctors alike, the market is shifting away from the one-size-fits-all philosophy toward biomarker-directed treatments that maximize treatment protocols and increase survivorship.

Integration of Artificial Intelligence in Biomarker Discovery

Artificial Intelligence (AI) is changing Australia's cancer biomarker scene at a quickening rate, and this trend is firmly backed by heavy government investment. In 2024, the MRFF provided $27 million to eight genomic research projects, including $8 million specifically earmarked for a consortium to create AI-driven tools for cancer diagnosis and treatment. This investment is part of the general trend to apply machine learning algorithms to process complex genomic and proteomic data to identify new biomarkers more rapidly and accurately. AI also supports diagnostic imaging and pathology through correlations of visual and molecular information to increase accuracy and personalize therapy. Australian biotech companies, universities, and foreign research institutes are collaborating to drive innovation. As AI technologies advance, they will automate biomarker discovery, cut diagnostic development time, and improve oncology care outcomes.

Expansion of Liquid Biopsy Technologies

Australia is witnessing fast growth in the use of liquid biopsy as a non-invasive technique for cancer detection and monitoring using biomarkers like circulating tumor DNA (ctDNA). It enables early diagnosis, real-time monitoring of treatment response, and detection of minimal residual disease without invasive tissue biopsies. Liquid biopsies are increasingly being adopted because they are convenient, safe, and have the potential to be used in screening high-risk populations. Australian research institutions and biotech firms are investing in the development of sophisticated liquid biopsy assays, particularly for difficult-to-biopsy tumors. Regulatory approval and growing clinical trials further confirm their application. As the technology advances, it is set to greatly increase the cancer biomarker market in diagnostics and treatment planning.

Australia Cancer Biomarkers Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country and regional for 2025-2033. Our report has categorized the market based on profiling technology, biomolecule, cancer type, application, and end user.

Profiling Technology Insights:

Omics Technologies
Imaging Technologies
Immunoassays
Cytogenetics

The report has provided a detailed breakup and analysis of the market based on the profiling technology. This includes omics technologies, imaging technologies, immunoassays, and cytogenetics.

Biomolecule Insights:

Genetic Biomarkers
Protein Biomarkers
Glyco-Biomarkers

A detailed breakup and analysis of the market based on the biomolecule have also been provided in the report. This includes genetic biomarkers, protein biomarkers, and glyco-biomarkers.

Cancer Type Insights:

Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Stomach
Others

The report has provided a detailed breakup and analysis of the market based on the cancer type. This includes breast cancer, lung cancer, colorectal cancer, prostate cancer, stomach, and others.

Application Insights:

Diagnostics
Prognostics
Risk Assessment
Drug Discovery and Development
Others

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes diagnostics, prognostics, risk assessment, drug discovery and development, and others.

End User Insights:

Hospitals
Academic and Research Institutions
Ambulatory Surgical Centers
Diagnostic Laboratories
Others

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, academic and research institutions, ambulatory surgical centers, diagnostic laboratories, and others.

Regional Insights:

Australia Capital Territory & New South Wales
Victoria & Tasmania
Queensland
Northern Territory & Southern Australia
Western Australia

The report has also provided a comprehensive analysis of all the major regional markets, which include Australia Capital Territory & New South Wales, Victoria & Tasmania, Queensland, Northern Territory & Southern Australia, and Western Australia.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Australia Cancer Biomarkers Market News:

In April 2025, The Institute of Cancer Research (ICR), London, and QBiotics partnered to study tigilanol tiglate, a potential cancer drug derived from Australia’s blushwood tree. Currently in clinical trials for head and neck cancers, the drug is injected directly into tumors and shows promise in destroying cancer cells, disrupting blood supply, and activating immune responses. Already approved for veterinary use, it is now being explored for human cancer treatment.

Australia Cancer Biomarkers Market Report Coverage:

Report Features	Details
Base Year of the Analysis	2024
Historical Period	2019-2024
Forecast Period	2025-2033
Units	Million USD
Scope of the Report	Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment: Profiling Technology Biomolecule Cancer Type Application End User Region
Profiling Technologies Covered	Omics Technologies, Imaging Technologies, Immunoassays, Cytogenetics
Biomolecules Covered	Genetic Biomarkers, Protein Biomarkers, Glyco-Biomarkers
Cancer Types Covered	Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Stomach, Others
Applications Covered	Diagnostics, Prognostics, Risk Assessment, Drug Discovery and Development, Others
End Users Covered	Hospitals, Academic and Research Institutions, Ambulatory Surgical Centers, Diagnostic Laboratories, Others
Regions Covered	Australia Capital Territory & New South Wales, Victoria & Tasmania, Queensland, Northern Territory & Southern Australia, Western Australia
Customization Scope	10% Free Customization
Post-Sale Analyst Support	10-12 Weeks
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report:

How has the Australia cancer biomarkers market performed so far and how will it perform in the coming years?
What is the breakup of the Australia cancer biomarkers market on the basis of profiling technology?
What is the breakup of the Australia cancer biomarkers market on the basis of biomolecule?
What is the breakup of the Australia cancer biomarkers market on the basis of cancer type?
What is the breakup of the Australia cancer biomarkers market on the basis of application?
What is the breakup of the Australia cancer biomarkers market on the basis of end user?
What is the breakup of the Australia cancer biomarkers market on the basis of region?
What are the various stages in the value chain of the Australia cancer biomarkers market?
What are the key driving factors and challenges in the Australia cancer biomarkers?
What is the structure of the Australia cancer biomarkers market and who are the key players?
What is the degree of competition in the Australia cancer biomarkers market?

Key Benefits for Stakeholders:

IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the Australia cancer biomarkers market from 2019-2033.
The research report provides the latest information on the market drivers, challenges, and opportunities in the Australia cancer biomarkers market.
Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the Australia cancer biomarkers industry and its attractiveness.
Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.

Need more help?

Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.

Purchase Options Discount
Offer

Inquire Before Buying

Speak to an Analyst

Request Brochure

Request Customization

Benefits of Customization

Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

IMARC did an outstanding job in preparing our study. They were punctual and precise, delivering all the data we required in a clear and well-organized format. Their attention to detail and ability to meet deadlines was impressive, making them a reliable partner for our project.

I wanted to express my sincere appreciation for your efforts in handling this matter. Your dedication and commitment have truly been commendable. It is evident that you have put in a tremendous amount of hard work and expertise into resolving the issues at hand. I would also like to take this opportunity to inform you that we are greatly interested

Overall, the deliverable was well organized and my experience with the project team was good. In particular, I appreciated how they responded when I requested additional information and the Japanese version.

The IMARC team were extremely professional and very cooperative. The team were also extremely flexible in making changes and modifications wherever required. The entire experience right from project kick-off to after sales support was fruitful and smooth.

I’d like to express my gratitude for the work you accomplished with the industry report. The way you responded to the requirements and delivered under tight timelines shows your expertise, exceptional work ethic and commitment to your customer’s success. The entire team and company are incredibly thankful for your dedication. Once again, thank you

The market reports from IMARC have been instrumental in guiding our business strategies. We found the reports comprehensive and data-driven, which helped us make informed decisions. The detailed insights and actionable data have consistently provided us with a competitive edge in a rapidly changing alcohol market.

One of the best things about IMARC is their flexibility and predisposition to tailor the reports and adapt to our needs. They are not just great in their researching and consulting solutions, but their service is unparallelled. We’ve worked with them a couple of times and we will keep working with them in future projects.

We recently commissioned multiple market research reports from IMARC, and the insights we received were invaluable. The depth of analysis, accuracy of data, and actionable recommendations have greatly enhanced our strategic decision-making.

The market estimates provided by your team were pretty much in line with what we were theorizing internally. Really appreciate the work on this.

The sale account manager and the service was excellent. The data and market trends gathered from the report was insightful and really assisted while planning future product and growth strategies.

The report is excellent and has good amount of data and our team is extremely happy with the information provided.

Thank you very much for your cooperation and post purchase support. We were really happy with the final deliverable, and the takeaways from the report.